{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:20Z","timestamp":1793332340183,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vaccine.2025.127044","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:53:39Z","timestamp":1743382419000},"page":"127044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine"],"prefix":"10.1016","volume":"55","author":[{"given":"E. Claire","family":"Newbern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Shoaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair","family":"Blacketer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Willame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeFalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowtham A.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourtney","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Anaya","family":"Velarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupa","family":"Makadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Schuemie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127044_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions\u202f: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"issue":"148","key":"10.1016\/j.vaccine.2025.127044_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archpedi.1994.02170050037007","article-title":"Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease","author":"Prevots","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2025.127044_bb0020","series-title":"European Medicines Agency EMA. European Union Risk Management Plan JCOVDEN (VAC31518 [Ad26.COV2.S])","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127044_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/sim.9968","article-title":"Bayesian safety surveillance with adaptive bias correction","volume":"43","author":"Bu","year":"2024","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127044_bb0035","doi-asserted-by":"crossref","unstructured":"Reich C, Ostropolets A, Ryan P, Rijnbeek P, Schuemie M, Davydov A, et al. OHDSI standardized vocabularies\u2014a large-scale centralized reference ontology for international data harmonization. J Am Med Inform Assoc,. 2024;ocad247: doi:https:\/\/doi.org\/10.1093\/jamia\/ocad247.","DOI":"10.1093\/jamia\/ocad247"},{"key":"10.1016\/j.vaccine.2025.127044_bb0040","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/jamia\/ocab132","article-title":"Increasing trust in real-world evidence through evaluation of observational data quality","volume":"28","author":"Blacketer","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.vaccine.2025.127044_bb0045","series-title":"Brighton Collaboration. Priority list of adverse events of special interest for COVID-19","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127044_bb0050","series-title":"Food and Drug Administration. Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring","year":"2021"},{"key":"10.1016\/j.vaccine.2025.127044_bb0055","author":"Gilbert"},{"key":"10.1016\/j.vaccine.2025.127044_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310634","article-title":"CohortDiagnostics: phenotype evaluation across a network of observational data sources using population-level characterization","volume":"20","author":"Rao","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127044_bb0065","author":"Swerdel"},{"key":"10.1016\/j.vaccine.2025.127044_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2022.104177","article-title":"PheValuator 2.0: methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation","volume":"135","author":"Swerdel","year":"2022","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2025.127044_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103258","article-title":"PheValuator: development and evaluation of a phenotype algorithm evaluator","volume":"97","author":"Swerdel","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2025.127044_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837632","article-title":"Current approaches to vaccine safety using observational data: a rationale for the EUMAEUS (evaluating use of methods for adverse events under surveillance-for vaccines) study design","volume":"13","author":"Lai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2025.127044_bb0085","article-title":"Vaccine safety surveillance using routinely collected healthcare data-an empirical evaluation of epidemiological designs","volume":"13","author":"Schuemie","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2025.127044_bb0090","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127044_bb0095","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/ije\/dyy120","article-title":"Evaluating large-scale propensity score performance through real-world and synthetic data experiments","volume":"47","author":"Tian","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127044_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2022.104204","article-title":"Adjusting for indirectly measured confounding using large-scale propensity score","volume":"134","author":"Zhang","year":"2022","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2025.127044_bb0105","series-title":"Evaluating the impact of instrumental variables in propensity score models using synthetic and negative control experiments. arXiv","author":"Tian","year":"2024"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127044_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.3263","article-title":"One-to-many propensity score matching in cohort studies","volume":"21","author":"Rassen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2025.127044_bb0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/sim.9631","article-title":"Adjusting for both sequential testing and systematic error in safety surveillance using observational data: empirical calibration and MaxSPRT","volume":"42","author":"Schuemie","year":"2023","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127044_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/09622802211060518","article-title":"Combining cox regressions across a heterogeneous distributed research network facing small and zero counts","volume":"31","author":"Schuemie","year":"2022","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.vaccine.2025.127044_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/sim.5925","article-title":"Interpreting observational studies: why empirical calibration is needed to correct p-values","volume":"33","author":"Schuemie","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2025.127044_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CER.S40357","article-title":"A tool for assessing the feasibility of comparative effectiveness research","volume":"2013","author":"Walker","year":"2013","journal-title":"Comparative Effectiveness Research"},{"key":"10.1016\/j.vaccine.2025.127044_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068373","article-title":"Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis","volume":"376","author":"Li","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127044_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8879","article-title":"Incidence of Guillain-Barre syndrome after COVID-19 vaccination in the vaccine safety datalink","volume":"5","author":"Hanson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127044_bb0145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.vaccine.2022.11.069","article-title":"Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older","volume":"41","author":"Wong","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127044_bb0150","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1016\/j.vaccine.2022.09.060","article-title":"Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years","volume":"40","author":"Lloyd","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127044_bb0155","author":"Sturkenboom"},{"key":"10.1016\/j.vaccine.2025.127044_bb0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2021.12.009","article-title":"Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines","volume":"40","author":"Botton","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127044_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071594","article-title":"Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US","volume":"379","author":"Li","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127044_bb0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40264-023-01324-1","article-title":"Serially combining epidemiological designs does not improve overall signal detection in vaccine safety surveillance","volume":"46","author":"Arshad","year":"2023","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2025.127044_bb0175","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1016\/j.vaccine.2022.09.060","article-title":"Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years","volume":"40","author":"Lloyd","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127044_bb0180","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.vaccine.2022.11.069","article-title":"Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older","volume":"41","author":"Wong","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127044_bb0185","series-title":"Encyclopedia of Biostatistics","author":"Rothman","year":"2005"},{"key":"10.1016\/j.vaccine.2025.127044_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.36469\/jheor.2023.87538","article-title":"Use of open claims vs closed claims in health outcomes research","volume":"10","author":"Baser","year":"2023","journal-title":"J Health Econ Outcomes Res"},{"key":"10.1016\/j.vaccine.2025.127044_bb0200","series-title":"US Centers for Disease Control and Prevention CDC. COVID-19 vaccinations in the United States,Jurisdiction","volume":"2023","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127044_bb0205","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.15585\/mmwr.mm7044e2","article-title":"The advisory committee on immunization Practices\u2019 interim recommendations for additional primary and booster doses of COVID-19 vaccines - United States, 2021","volume":"70","author":"Mbaeyi","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127044_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.880050206","article-title":"Sources of error in the diagnosis of Guillain-Barre syndrome","volume":"5","author":"Feit","year":"1982","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2025.127044_bb0220","series-title":"US Federal Drug Administration FDA. Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory DecisionMaking for Drug and Biological Products: Guidance for Industry","volume":"2021","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127044_bb0225","author":"Layton"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:09:19Z","timestamp":1762456159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"alternative-id":["S0264410X2500341X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127044"}}